ARCHIVES

In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford

This article is from The Cancer Letter archive.

Vol. 03 No. 10 | March 11, 1977

Download PDF Visit The Full Archive

Related Articles

Cancer Care Uneven, IOM’s National Cancer Policy Board Concludes

April 9, 1999

From Long Island To Houston By Rental Care, In 43 Hours.

October 5, 2001

Special Report on the American Legacy Foundation: As Legacy seeks new funding, critics fear symbiosis with Big Tobacco. Legacy, NCI, C-Change relationship could open door to industry influence, lawyer says.

October 29, 2004

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996

Three Genetics Pioneers Win Nobel Prize

October 11, 2002

Shortfall In Centers Budget Threatens Grants Of Half Of The 17 Competing For Renewal In 1980

October 12, 1979